Skip to content
Recall Observatory FDA recall evidence

Drug product

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

D-238-2013

March 19, 2013

Class III

Product summary

Firm
Dr. Reddy'S Laboratories
Event
Event 64733
Status
Terminated
Classification
Class III
Quantity
117,546 bottles
Official record key
drug-enforcement:D-238-2013

Official wording

Reason: Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Code information: Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.

Distribution pattern: Nationwide and Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.